There have been many surprise developments and, unfortunately, multiple league-altering injuries in the early stages of the 2025 NFL season, thus, affecting next year’s draft. As such, our predicted ...

FedEx Corp (NYSE:FDX) delivered its financial results for the first quarter of fiscal 2026 on Thursday after the bell. Here’s a look at the key details from the report. FDX stock is racing ahead of ...

First Three Halloween Movies Get Amazon-Exclusive 4K Steelbooks John Carpenter's classic 1978 slasher movie is available now, and fans can preorder collectible 4K Blu-ray editions of Halloween II and ...

GameSpot may get a commission from retail offers. During Gamescom Opening Night Live, Wargaming unveiled World of Tanks 2.0, a massive update to the 15-year-old free-to-play tank battle game, which ...

The 2026 Hyundai Palisade has just made my job harder—and easier. It’s a well-worn auto journalist trope that most of us love minivans, almost as much as we love suggesting them to would-be buyers. It ...

Momentum is building for quantum computing and some observers say that a usable, fault-tolerant quantum system could appear in the next few years. We have written ...

Philippine housing unit prices saw an increase in the first quarter of 2025, albeit at a slower pace, driven by higher prices in the National Capital Region (NCR), the Bangko Sentral ng Pilipinas (BSP ...

Bell, a Textron subsidiary, has delivered to the U.S. Army the first virtual prototype of the MV-75 Future Long Range Assault Aircraft, or FLRAA. A second virtual prototype of the FLRAA is expected to ...

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan 48109, United States ...

After spending the week in Buffalo, N.Y., at the NHL Scouting Combine, here’s my second version of a first-round mock for the 2025 NHL Draft. These are my best predictions for the first 32 picks after ...

*Note: One patient in each cohort finished treatment without at least one post-baseline tumor assessment. Among the patients with PD-L1 TPS<1%, IBI363 demonstrated outstanding efficacy signals: in the ...

Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study Participants had ...